519 articles in this topic
Children with sepsis and elevated procalcitonin show measurable microvascular dysfunction, higher organ failure rates, and increased mortality.
Major cardiology societies overhaul training requirements for cardiac electrophysiology fellows, reflecting a decade of advances in arrhythmia care.
A 160-patient RCT shows LBBP dramatically reduces pacing-induced cardiomyopathy and preserves heart function over 3 years.
A 965-patient RCT shows omitting defibrillation testing during subcutaneous ICD implantation is non-inferior to routine testing when device position is scored by chest X-ray.
A longevity-linked protein blocks two key mechanisms of doxorubicin heart damage, offering a potential cardioprotective strategy for cancer patients.
A protein linked to cardiovascular protection predicts mitral valve deterioration and heart failure risk after STEMI, opening a new prognostic window.
New evidence suggests oral semaglutide sustains long-term improvements in key CVD risk factors, expanding its role beyond diabetes management.
A landmark AHA statement challenges decades of blanket activity restrictions for children with cardiomyopathy, offering new risk-stratified guidance.
Isoquercitrin reshapes gut bacteria and tryptophan metabolism to reduce arterial plaque, pointing to a novel gut-heart therapeutic pathway.
A sirtuin enzyme prevents heart scarring by keeping cardiac fibroblasts from switching to a pro-fibrotic metabolic state.
A landmark review maps how computational heart models can decode diabetic cardiomyopathy and predict responses to SGLT2i and GLP-1 drugs.
Researchers defend their findings on screening-detected atrial fibrillation and cardiovascular outcomes in younger adults.
